SFWA
AGN

Summit Financial Wealth Advisors’s Allergan plc AGN Stock Holding History

Summit Financial Wealth Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-884
Closed -$204K – 151
2016
Q3 		$204K Sell
884
-12
-1% -$2.93K 0.09% 137
2016
Q2 		$207K Sell
896
-93
-9% -$21.4K 0.09% 135
2016
Q1 		$265K Sell
989
-58
-6% -$16.6K 0.12% 114
2015
Q4 		$327K Buy
1,047
+1,007
+2,518% +$300K 0.15% 103
2015
Q3 		$10K Sell
40
-17
-30% -$5.22K 0.01% 188
2015
Q2 		$17K Hold
57
– – 0.01% 208
2015
Q1 		$17K Hold
57
– – 0.01% 177
2014
Q4 		$15K Buy
+57
New +$14.2K 0.01% 185

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Summit Financial Wealth Advisors's AGN Position: Q4 2016 in Review

Summit Financial Wealth Advisors sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 884 shares — an estimated $204K sold.

Summit Financial Wealth Advisors first reported a position in AGN in Q4 2014 and held it in 8 quarters. The position peaked at $327K in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Summit Financial Wealth Advisors reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Summit Financial Wealth Advisors sold 884 Allergan plc shares in Q4 2016, an estimated $204K.
  • Summit Financial Wealth Advisors first reported a position in Allergan plc in Q4 2014 and held it in 8 quarters.
  • Summit Financial Wealth Advisors's Allergan plc position peaked at $327K in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Summit Financial Wealth Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.